Literature DB >> 21755492

[Structural differences between health insurance funds and their impact on health services research: results from the Bertelsmann Health-Care Monitor].

F Hoffmann1, A Icks.   

Abstract

AIM: Claims data of health insurance companies are an important database for health services research. We investigated if there are differences in baseline characteristics and prevalence of chronic diseases between members of several health insurance funds in Germany, and if so, whether adjusting for age and sex could explain these differences.
METHODS: 10 representative surveys (conducted between 2004 and 2008) of the 'Bertelsmann Health-Care Monitor' comprising 15 089 participants aged 18 to 79 years were analysed. Our main independent variable was membership in one of 8 health insurance funds. The prevalence of self-reported hypertension, diabetes, atopic diseases, coronary heart disease and heart failure was studied. We first estimated the crude prevalence of chronic diseases stratified by these funds. We further fitted logistic regression models and adjusted for age and sex as well as for further comorbidities and health related factors.
RESULTS: Most respondents were insured in the BKK (Betriebskrankenkassen; 20.1%), the AOK (Allgemeinen Ortskrankenkassen; 19.2%) and private health insurances (15.3%). Substantial differences were found according to age, sex, educational level and prevalences of chronic diseases. Stratified by health insurance funds, prevalences ranged between 17.1-29.6% for hypertension, between 3.9-11.4% for diabetes, between 4.3-6.7% for atopic diseases, between 3.4-6.7% for coronary heart disease and between 2.6-5.7% for heart failure. When adjusting for sex and age, estimates for all 5 diseases were significant higher in AOK members compared to privately insured persons (3 diseases within the BAMER and the DAK, accordingly). In total, this was the case for 17 out of 35 comparisons. Even after adjusting for further comorbidities and health related factors 6 out of 35 comparisons showed significant increased estimates compared to privately insured persons.
CONCLUSION: We found considerable differences in the prevalence of chronic diseases between German health insurance funds that remained after controlling for age and sex, and even after adjustment for further health-related variables. Further methodological studies are urgently needed to assess strengths and weaknesses of German claim data. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 21755492     DOI: 10.1055/s-0031-1275711

Source DB:  PubMed          Journal:  Gesundheitswesen        ISSN: 0941-3790


  87 in total

1.  [Prescription of TNF-alpha inhibitors and regional differences in 2010].

Authors:  R Windt; G Glaeske; F Hoffmann
Journal:  Z Rheumatol       Date:  2011-12       Impact factor: 1.372

2.  [Differences in chronic back pain and joint disorders among health insurance funds : Results of a cross-sectional study based on the data of the Socioeconomic Panel from 2013].

Authors:  A Luque Ramos; F Hoffmann
Journal:  Z Rheumatol       Date:  2017-04       Impact factor: 1.372

3.  The management of thyroid nodules: a retrospective analysis of health insurance data.

Authors:  Romy Wienhold; Markus Scholz; J Rgen-Bernhard Adler; Christian G Nster; Ralf Paschke
Journal:  Dtsch Arztebl Int       Date:  2013-12-06       Impact factor: 5.594

4.  Guidelines versus reality: is coronary stent application in three-vessel disease standard or the exception?

Authors:  Roland Linder; J Zeidler; F Verheyen; J-M Graf von der Schulenburg; A Haverich; T Schilling
Journal:  Eur J Health Econ       Date:  2017-08-19

5.  Mortality and hospitalization at the end of life in newly admitted nursing home residents with and without dementia.

Authors:  Katharina Allers; Falk Hoffmann
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2018-05-02       Impact factor: 4.328

6.  Variation in antibiotic prescriptions: is area deprivation an explanation? Analysis of 1.2 million children in Germany.

Authors:  D Koller; F Hoffmann; W Maier; K Tholen; R Windt; G Glaeske
Journal:  Infection       Date:  2012-07-24       Impact factor: 3.553

7.  The Epidemiology of Acute Liver Failure.

Authors:  Nina Weiler; Andreas Schlotmann; Andreas Anton Schnitzbauer; Stefan Zeuzem; Martin-Walter Welker
Journal:  Dtsch Arztebl Int       Date:  2020-01-24       Impact factor: 5.594

8.  Epidemiology and use of compression treatment in venous leg ulcers: nationwide claims data analysis in Germany.

Authors:  Kristina Heyer; Kerstin Protz; Gerd Glaeske; Matthias Augustin
Journal:  Int Wound J       Date:  2016-05-19       Impact factor: 3.315

9.  [Prevalence of rheumatoid arthritis in Germany based on health insurance data : Regional differences and first results of the PROCLAIR study].

Authors:  S Hense; A Luque Ramos; J Callhoff; K Albrecht; A Zink; F Hoffmann
Journal:  Z Rheumatol       Date:  2016-10       Impact factor: 1.372

10.  Morbidity and mortality after surgery for lower urinary tract symptoms: a study of 95 577 cases from a nationwide German health insurance database.

Authors:  C Gilfrich; H Leicht; C Fahlenbrach; E Jeschke; G Popken; J U Stolzenburg; L Weißbach; C Zastrow; C Günster
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-08-09       Impact factor: 5.554

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.